Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Vertex Q4 results miss on bottom line; 2026 revenue guidance in-line

Vertex Q4 results miss on bottom line; 2026 revenue guidance in-line

Feb 12, 2026

Post navigation

VistaGen Therapeutics GAAP EPS of -$0.45 beats by $0.04, revenue of $0.30M beats by $0.16M

PTC Therapeutics Provides Regulatory Update on Translarna™

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: